Kiniksa Pharmaceuticals, Ltd. - COM CL A (KNSA)

Historical Portfolio Holders from Q2 2018 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM CL A
Shares, excl. options Q1 2024
37.6 M
Holdings value Q1 2024
$742 M
Value change Q1 2024
+$104 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
149
Number of buys Q1 2024
82
Number of sells Q1 2024
-67
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.001%
CUSIP
G5269C101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 37.6 M $742 M +$104 M $19.73 150
2023 Q4 32.6 M $571 M -$47 M $17.54 140
2023 Q3 34.8 M $605 M +$53.6 M $17.37 134
2023 Q2 31.7 M $446 M +$4.82 M $14.08 125
2023 Q1 31.4 M $338 M +$13.1 M $10.76 129
2022 Q4 29.8 M $446 M +$8.59 M $14.98 122
2022 Q3 29.4 M $378 M +$7.9 M $12.84 101
2022 Q2 28.8 M $279 M -$8.49 M $9.69 85
2022 Q1 30.3 M $301 M +$13.4 M $9.94 88
2021 Q4 29.3 M $345 M +$3.16 M $11.77 98
2021 Q3 29.1 M $332 M -$3.1 M $11.39 95
2021 Q2 28.8 M $401 M -$17.1 M $13.93 96
2021 Q1 29 M $537 M -$12.1 M $18.51 100
2020 Q4 29.8 M $526 M +$25.1 M $17.67 107
2020 Q3 28.3 M $433 M +$112 M $15.32 98
2020 Q2 21.1 M $538 M +$101 M $25.48 92
2020 Q1 17.7 M $274 M +$44.3 M $15.48 70
2019 Q4 15.1 M $167 M -$137 K $11.06 55
2019 Q3 15.5 M $132 M -$16.9 M $8.51 49
2019 Q2 16.5 M $223 M +$1.37 M $13.54 57
2019 Q1 16.3 M $294 M +$33.9 M $18.06 52
2018 Q4 13.7 M $385 M -$47.9 M $28.09 50
2018 Q3 14.4 M $363 M -$79.1 M $25.50 53
2018 Q2 17.3 M $298 M +$298 M $17.35 41